Buscar resultados de ensayos clínicos
Nasopharyngeal Carcinoma - 31 Studies Found
Estado | Estudiar |
RECRUITING |
Nombre del estudio: Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal Carcinoma Condición: Nasopharyngeal Carcinoma Fecha: 2024-05-20 Intervenciones: Camrelizumab 200mg every 21 days (3 weeks) for up to 18 cycles, from 4 to 12 weeks after the completion of radiotherapy. |